Updates are available Correction dated 2024-02-13
Click to view Correction: https://doi.org/10.1038/s41541-024-00820-4
Updates are available Correction dated 2024-12-09
Click to view Correction: https://doi.org/10.1038/s41541-024-01027-3
-
Authors
Natali, Eriberto Noel https://orcid.org/0000-0002-9100-807X
Horst, Alexander
Meier, Patrick https://orcid.org/0000-0002-8585-6208
Greiff, Victor https://orcid.org/0000-0003-2622-5032
Nuvolone, Mario https://orcid.org/0000-0001-8334-1684
Babrak, Lmar Marie
Fink, Katja https://orcid.org/0000-0002-3571-0390
Miho, Enkelejda https://orcid.org/0000-0001-6461-0519
-
Funding
Funding for this research was provided by:
Wellcome Trust (215840/Z/19/Z, 215840/Z/19/Z, 215840/Z/19/Z, 215840/Z/19/Z)
- License Information
-
More Information
Article History
Received: 1 December 2022
Accepted: 7 December 2023
First Online: 20 January 2024
Change Date: 13 February 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-024-00820-4
Change Date: 9 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41541-024-01027-3
Competing interests
: Network algorithms for computational antibody discovery pipelines implemented in this publication are part of the aiNET discovery pipeline. Prof. Dr. Enkelejda Miho is the founder, managing director and owns shares in aiNET GmbH. Prof. Dr. Victor Greiff is in the scientific advisory board of aiNET GmbH.
